Patent directory · USPTO A61K / A61P
Patents matching “Arrowhead Pharmaceuticals, Inc.”
89 pharma patents match "Arrowhead Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 89 pharmaceutical patents matching "Arrowhead Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12378558
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use
granted -
US 12365899
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
granted -
US 12365897
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereof, and methods of use
granted -
US 12221610
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use
granted -
US 12188017
Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin
granted -
US 12173086
Alpha-v beta-6 integrin ligands and uses thereof
granted -
US 12116573
Targeting ligands for therapeutic compounds
granted -
US 12110492
RNAi agents for inhibiting expression of complement component C3 (C3), pharmaceutical compositions thereof, and methods of use
granted -
US 12091661
Organic compositions to treat HSF1-related diseases
granted -
US 12065458
Trialkyne linking agents and methods of use
granted -
US 12054718
RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of use
granted -
US 11920134
Compositions and methods for inhibiting expression of RRM2 genes
granted -
US 11912997
RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use
granted -
US 11884920
Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
granted -
US 11845937
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
granted -
US 11840688
Compositions and methods for inhibiting gene expression of Hif2alpha
granted -
US 11629349
RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use
granted -
US 11597701
Integrin ligands and uses thereof
granted -
US 11590156
RNAi agents for hepatitis B virus infection
granted -
US 11549112
RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use
granted -
US 11534453
RNAi therapy for hepatitis B virus infection
granted -
US 11517584
RNAi agents for Hepatitis B virus infection
granted -
US 11492624
RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1
granted -
US 11384355
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
granted